BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8285164)

  • 1. [Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
    Okumura A; Muraishi Y; Tsuritani S; Sakamoto M; Kazama T; Fuse H; Katayama T
    Hinyokika Kiyo; 1993 Dec; 39(12):1157-61. PubMed ID: 8285164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
    Kobayashi Y
    Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MRSA infections in surgery].
    Fujita K; Suzuki T; Kato H; Nagamachi Y; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):813-9. PubMed ID: 8072191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
    Ochiai M; Tanimura H; Noguchi K; Takifuji K; Konishi R; Ohkouchi N; Kouno N; Ohnishi H; Shimada K; Kasitani M
    Jpn J Antibiot; 1994 Jun; 47(6):837-43. PubMed ID: 8072194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy of arbekacin on MRSA infections].
    Ichiyama S; Shimokata K
    Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
    Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
    Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
    Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
    Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
    Hayashi I; Inoue M; Hashimoto H
    Drugs Exp Clin Res; 1994; 20(6):225-32. PubMed ID: 7758394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
    Sotozono C; Inagaki K; Fujita A; Koizumi N; Sano Y; Inatomi T; Kinoshita S
    Cornea; 2002 Oct; 21(7 Suppl):S94-101. PubMed ID: 12484707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
    Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
    Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gram-positive cocci (include MRSA)].
    Tsuji A
    Nihon Rinsho; 1994 Feb; 52(2):359-66. PubMed ID: 8126886
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) in Japan until 1993].
    Hashimoto H
    Jpn J Antibiot; 1994 Jun; 47(6):575-84. PubMed ID: 8072165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of MRSA infections].
    Inamatsu T
    Nihon Naika Gakkai Zasshi; 1992 Oct; 81(10):1662-7. PubMed ID: 1469319
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
    Hayashi I; Inoue M; Hashimoto H
    Jpn J Antibiot; 1994 Jun; 47(6):595-605. PubMed ID: 8072167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Special issue: Current state of MRSA infections and practical chemotherapy with arbekacin].
    Jpn J Antibiot; 1994 Jun; 47(6):561-843. PubMed ID: 8072164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
    Arakawa M; Wada K; Sega H; Yoshikawa H; Honma T; Miyao H; Shimazu Y; Tsukada H; Hoshino S; Sato S
    Jpn J Antibiot; 1994 Jun; 47(6):736-40. PubMed ID: 8072182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methicillin resistant Staphylococcus aureus infection].
    Fukayama M
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):179-81. PubMed ID: 10088367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of cancer and counter-measures for MRSA infections].
    Tanaka K; Tokunaga N; Natori H; Oizumi K
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):409-16. PubMed ID: 8129380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.